Cargando…

Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review

RATIONALE: Occult breast cancer (OBC) is extremely rare in males with neither symptoms in the breast nor abnormalities upon imaging examination. PATIENT CONCERNS: This current case report presents a young male patient who was diagnosed with male OBC first manifesting as axillary lymph node metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ruixin, Li, Jianbin, Zhang, Yingjie, Jing, Hongbiao, Zhu, Youzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758204/
https://www.ncbi.nlm.nih.gov/pubmed/29390502
http://dx.doi.org/10.1097/MD.0000000000009312
_version_ 1783290964075347968
author Xu, Ruixin
Li, Jianbin
Zhang, Yingjie
Jing, Hongbiao
Zhu, Youzhe
author_facet Xu, Ruixin
Li, Jianbin
Zhang, Yingjie
Jing, Hongbiao
Zhu, Youzhe
author_sort Xu, Ruixin
collection PubMed
description RATIONALE: Occult breast cancer (OBC) is extremely rare in males with neither symptoms in the breast nor abnormalities upon imaging examination. PATIENT CONCERNS: This current case report presents a young male patient who was diagnosed with male OBC first manifesting as axillary lymph node metastasis. The physical and imaging examination showed no primary lesions in either breasts or in other organs. DIAGNOSES: The pathological results revealed infiltrating ductal carcinoma in the axillary lymph nodes. Immunohistochemical (IHC) staining was negative for estrogen receptor (ER), progesterone receptor (PR), cytokeratin (CK)20 and thyroid transcription factor-1 (TTF-1), positive for CK7, gross cystic disease fluid protein-15 (GCDFP-15), epithelial membrane antigen (EMA) and carcinoembryonic antigen (CEA), and suspicious positive for human epidermal receptor-2 (Her-2). On basis of IHC markers, particularly such as CK7, CK20 and GCDFP-15, and eliminating other malignancies, male OBC was identified in spite of negativity for hormone receptors. INTERVENTIONS: The patient underwent left axillary lymph node dissection (ALND) but not mastectomy. After the surgery, the patient subsequently underwent chemotherapy and radiotherapy. OUTCOMES: The patient is currently being followed up without any signs of recurrence. LESSONS: Carefully imaging examination and pathological analysis were particularly essential in the diagnosis of male OBC. The guidelines for managing male OBC default to those of female OBC and male breast cancer.
format Online
Article
Text
id pubmed-5758204
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-57582042018-01-29 Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review Xu, Ruixin Li, Jianbin Zhang, Yingjie Jing, Hongbiao Zhu, Youzhe Medicine (Baltimore) 5750 RATIONALE: Occult breast cancer (OBC) is extremely rare in males with neither symptoms in the breast nor abnormalities upon imaging examination. PATIENT CONCERNS: This current case report presents a young male patient who was diagnosed with male OBC first manifesting as axillary lymph node metastasis. The physical and imaging examination showed no primary lesions in either breasts or in other organs. DIAGNOSES: The pathological results revealed infiltrating ductal carcinoma in the axillary lymph nodes. Immunohistochemical (IHC) staining was negative for estrogen receptor (ER), progesterone receptor (PR), cytokeratin (CK)20 and thyroid transcription factor-1 (TTF-1), positive for CK7, gross cystic disease fluid protein-15 (GCDFP-15), epithelial membrane antigen (EMA) and carcinoembryonic antigen (CEA), and suspicious positive for human epidermal receptor-2 (Her-2). On basis of IHC markers, particularly such as CK7, CK20 and GCDFP-15, and eliminating other malignancies, male OBC was identified in spite of negativity for hormone receptors. INTERVENTIONS: The patient underwent left axillary lymph node dissection (ALND) but not mastectomy. After the surgery, the patient subsequently underwent chemotherapy and radiotherapy. OUTCOMES: The patient is currently being followed up without any signs of recurrence. LESSONS: Carefully imaging examination and pathological analysis were particularly essential in the diagnosis of male OBC. The guidelines for managing male OBC default to those of female OBC and male breast cancer. Wolters Kluwer Health 2017-12-22 /pmc/articles/PMC5758204/ /pubmed/29390502 http://dx.doi.org/10.1097/MD.0000000000009312 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5750
Xu, Ruixin
Li, Jianbin
Zhang, Yingjie
Jing, Hongbiao
Zhu, Youzhe
Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review
title Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review
title_full Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review
title_fullStr Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review
title_full_unstemmed Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review
title_short Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review
title_sort male occult breast cancer with axillary lymph node metastasis as the first manifestation: a case report and literature review
topic 5750
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758204/
https://www.ncbi.nlm.nih.gov/pubmed/29390502
http://dx.doi.org/10.1097/MD.0000000000009312
work_keys_str_mv AT xuruixin maleoccultbreastcancerwithaxillarylymphnodemetastasisasthefirstmanifestationacasereportandliteraturereview
AT lijianbin maleoccultbreastcancerwithaxillarylymphnodemetastasisasthefirstmanifestationacasereportandliteraturereview
AT zhangyingjie maleoccultbreastcancerwithaxillarylymphnodemetastasisasthefirstmanifestationacasereportandliteraturereview
AT jinghongbiao maleoccultbreastcancerwithaxillarylymphnodemetastasisasthefirstmanifestationacasereportandliteraturereview
AT zhuyouzhe maleoccultbreastcancerwithaxillarylymphnodemetastasisasthefirstmanifestationacasereportandliteraturereview